Ethics lobby forces rethink on growth hormones.
D002648:Child; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D035061:Control Groups; D004274:DNA, Recombinant; D026724:Ethical Review; D004989:Ethics; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006130:Growth Disorders; D006262:Health; D006728:Hormones; D006805:Human Experimentation; D006801:Humans; D007603:Jurisprudence; D009316:National Institutes of Health (U.S.); D033281:Nontherapeutic Human Experimentation; D005791:Patient Care; D004364:Pharmaceutical Preparations; D010919:Placebos; D011057:Politics; D012107:Research Design; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D014424:Turner Syndrome; D014481:United States
Biomedical and Behavioral Research; Foundation on Economic Trends; Legal Approach; National Institutes of Health; Physicians Committee for Responsible Medicine; University of Nebraska